Nivin N Nyström1, Amanda M Hamilton1, Wenyao Xia, Shirley Liu2, Timothy J Scholl1,3, John A Ronald1,4. 1. Medical Imaging Laboratories, Robarts Research Institute, London, Ontario. 2. Department of Medical Sciences, University of Western Ontario, London, Ontario. 3. Ontario Institute for Cancer Research, MaRS Centre, Toronto, Ontario. 4. Lawson Health Research Institute, London, Ontario, Canada.
Abstract
OBJECTIVES: Multimodality reporter gene imaging provides valuable, noninvasive information on the fate of engineered cell populations. To complement magnetic resonance imaging (MRI) measures of tumor volume and 2-dimensional reporter-based optical measures of cell viability, reporter-based MRI may offer 3-dimensional information on the distribution of viable cancer cells in deep tissues. MATERIALS AND METHODS: Here, we engineered human and murine triple-negative breast cancer cells with lentivirus encoding tdTomato and firefly luciferase for fluorescence imaging and bioluminescence imaging (BLI). A subset of these cells was additionally engineered with lentivirus encoding organic anion transporting polypeptide 1a1 (Oatp1a1) for MRI. Oatp1a1 operates by transporting gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) into cells, and it concomitantly improves BLI substrate uptake. After orthotopic implantation of engineered cells expressing or not expressing Oatp1a1, longitudinal fluorescence imaging, BLI, and 3-Tesla MRI were performed. RESULTS: Oatp1a1-expressing tumors displayed significantly increased BLI signals relative to control tumors at all time points (P < 0.05). On MRI, post-Gd-EOB-DTPA T1-weighted images of Oatp1a1-expressing tumors exhibited significantly increased contrast-to-noise ratios compared with control tumors and precontrast images (P < 0.05). At endpoint, tumors expressing Oatp1a1 displayed intratumoral MR signal heterogeneity not present at earlier time points. Pixel-based analysis of matched in vivo MR and ex vivo fluorescence microscopy images revealed a strong, positive correlation between MR intensity and tdTomato intensity for Oatp1a1-expressing tumors (P < 0.05), but not control tumors. CONCLUSIONS: These results characterize Oatp1a1 as a sensitive, quantitative, positive contrast MRI reporter gene for 3-dimensional assessment of viable cancer cell intratumoral distribution and concomitant BLI enhancement. This multimodality reporter gene system can provide new insights into the influence of viable cancer cell intratumoral distribution on tumor progression and metastasis, as well as improved assessments of anticancer therapies.
OBJECTIVES: Multimodality reporter gene imaging provides valuable, noninvasive information on the fate of engineered cell populations. To complement magnetic resonance imaging (MRI) measures of tumor volume and 2-dimensional reporter-based optical measures of cell viability, reporter-based MRI may offer 3-dimensional information on the distribution of viable cancer cells in deep tissues. MATERIALS AND METHODS: Here, we engineered human and murine triple-negative breast cancer cells with lentivirus encoding tdTomato and firefly luciferase for fluorescence imaging and bioluminescence imaging (BLI). A subset of these cells was additionally engineered with lentivirus encoding organic anion transporting polypeptide 1a1 (Oatp1a1) for MRI. Oatp1a1 operates by transporting gadoliniumethoxybenzyl diethylenetriamine pentaacetic acid (Gd-EOB-DTPA) into cells, and it concomitantly improves BLI substrate uptake. After orthotopic implantation of engineered cells expressing or not expressing Oatp1a1, longitudinal fluorescence imaging, BLI, and 3-Tesla MRI were performed. RESULTS:Oatp1a1-expressing tumors displayed significantly increased BLI signals relative to control tumors at all time points (P < 0.05). On MRI, post-Gd-EOB-DTPA T1-weighted images of Oatp1a1-expressing tumors exhibited significantly increased contrast-to-noise ratios compared with control tumors and precontrast images (P < 0.05). At endpoint, tumors expressing Oatp1a1 displayed intratumoral MR signal heterogeneity not present at earlier time points. Pixel-based analysis of matched in vivo MR and ex vivo fluorescence microscopy images revealed a strong, positive correlation between MR intensity and tdTomato intensity for Oatp1a1-expressing tumors (P < 0.05), but not control tumors. CONCLUSIONS: These results characterize Oatp1a1 as a sensitive, quantitative, positive contrast MRI reporter gene for 3-dimensional assessment of viable cancer cell intratumoral distribution and concomitant BLI enhancement. This multimodality reporter gene system can provide new insights into the influence of viable cancer cell intratumoral distribution on tumor progression and metastasis, as well as improved assessments of anticancer therapies.
Authors: Nourhan Shalaby; John Kelly; Francisco Martinez; Mathew Fox; Qi Qi; Jonathan Thiessen; Justin Hicks; Timothy J Scholl; John A Ronald Journal: Mol Imaging Biol Date: 2022-02-10 Impact factor: 3.484
Authors: John J Kelly; Moe Saee-Marand; Nivin N Nyström; Melissa M Evans; Yuanxin Chen; Francisco M Martinez; Amanda M Hamilton; John A Ronald Journal: Sci Adv Date: 2021-01-20 Impact factor: 14.136
Authors: Krishanu Saha; Erik J Sontheimer; P J Brooks; Melinda R Dwinell; Charles A Gersbach; David R Liu; Stephen A Murray; Shengdar Q Tsai; Ross C Wilson; Daniel G Anderson; Aravind Asokan; Jillian F Banfield; Krystof S Bankiewicz; Gang Bao; Jeff W M Bulte; Nenad Bursac; Jarryd M Campbell; Daniel F Carlson; Elliot L Chaikof; Zheng-Yi Chen; R Holland Cheng; Karl J Clark; David T Curiel; James E Dahlman; Benjamin E Deverman; Mary E Dickinson; Jennifer A Doudna; Stephen C Ekker; Marina E Emborg; Guoping Feng; Benjamin S Freedman; David M Gamm; Guangping Gao; Ionita C Ghiran; Peter M Glazer; Shaoqin Gong; Jason D Heaney; Jon D Hennebold; John T Hinson; Anastasia Khvorova; Samira Kiani; William R Lagor; Kit S Lam; Kam W Leong; Jon E Levine; Jennifer A Lewis; Cathleen M Lutz; Danith H Ly; Samantha Maragh; Paul B McCray; Todd C McDevitt; Oleg Mirochnitchenko; Ryuji Morizane; Niren Murthy; Randall S Prather; John A Ronald; Subhojit Roy; Sushmita Roy; Venkata Sabbisetti; W Mark Saltzman; Philip J Santangelo; David J Segal; Mary Shimoyama; Melissa C Skala; Alice F Tarantal; John C Tilton; George A Truskey; Moriel Vandsburger; Jonathan K Watts; Kevin D Wells; Scot A Wolfe; Qiaobing Xu; Wen Xue; Guohua Yi; Jiangbing Zhou Journal: Nature Date: 2021-04-07 Impact factor: 69.504
Authors: Nathan M Good; Harvey D Lee; Emily R Hawker; Morgan Z Su; Assaf A Gilad; N Cecilia Martinez-Gomez Journal: Front Microbiol Date: 2022-03-17 Impact factor: 5.640
Authors: Song Ee Baek; Asad Ul-Haq; Dae Hee Kim; Hyoung Wook Choi; Myeong Jin Kim; Hye Jin Choi; Honsoul Kim Journal: Korean J Radiol Date: 2020-06 Impact factor: 3.500
Authors: Or Perlman; Hirotaka Ito; Assaf A Gilad; Michael T McMahon; E Antonio Chiocca; Hiroshi Nakashima; Christian T Farrar Journal: Sci Rep Date: 2020-11-26 Impact factor: 4.379